|
Press Releases |
|
|
|
Monday, June 26, 2023 |
|
Tashi:真正無服務器遊戲已經來臨 |
Tashi是一家創新公司,開發了專有技術,並從隱藏模式中嶄露頭角,推出了一種真正的無服務器、無領導的P2P多人遊戲後端。 more info >> |
|
Tashi:真正无服务器游戏已经来临 |
Tashi是一家创新公司,开发了专有技术,并从隐藏模式中崭露头角,推出了一种真正的无服务器、无领导的P2P多人游戏后端。 more info >> |
|
Saturday, June 24, 2023 |
|
Tashi: True Serverless Gaming is Here |
Tashi, an innovative company developing proprietary technology has emerged from stealth mode to introduce a truly serverless, leaderless P2P multiplayer game backend. Tashi (www.tashi.gg) is demonstrating how distributed ledger technology can be used to dramatically reduce server costs and completely eliminate certain categories of cheating in real-time multiplayer gaming. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
TACACS.net: Strengthening Network Security with Native Active Directory Integration
Dec 5, 2024 06:30 HKT/SGT
|
|
|
Maxon One Winter Release Brings Holiday Cheer from Concept to Render
Dec 5, 2024 00:00 HKT/SGT
|
|
|
中信国际电讯CPC荣获三项业界大奖 内外展现网络安全实力
Dec 4, 2024 23:05 HKT/SGT
|
|
|
中信國際電訊CPC榮獲三項業界大獎 內外展現網絡安全實力
Dec 4, 2024 23:00 HKT/SGT
|
|
|
Naoris Protocol announces World's First Post-Quantum DePIN for Cybersecurity & Digital Trust ahead of Testnet
Dec 4, 2024 22:26: JST
|
|
|
Autobrains and JOYNEXT Revolutionize Smart Camera Solution Powered by Autobrains' Affordable Safety ADAS Software
Dec 4, 2024 22:20 HKT/SGT
|
|
|
CITIC Telecom CPC's Internal and External Cybersecurity Excellence Honored with 3 Industry Awards
Dec 4, 2024 22:10 HKT/SGT
|
|
|
25th Hong Kong Forum concludes successfully
Dec 4, 2024 22:00: JST
|
|
|
Naoris Protocol announces World's First Post-Quantum DePIN for Cybersecurity & Digital Trust ahead of Testnet
Dec 4, 2024 21:26 HKT/SGT
|
|
|
25th Hong Kong Forum concludes successfully
Dec 4, 2024 21:00 HKT/SGT
|
|
|
DENSO Signs Memorandum of Understanding with Canatu of Finland for Practical Application of Carbon Nanotube Technology
Dec 4, 2024 17:51 JST
|
|
|
Sweetness Affecting Both the Young and Old: Prevent Diabetes with LAC This World Diabetes Day
Dec 4, 2024 14:30 HKT/SGT
|
|
|
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
Dec 4, 2024 11:08 HKT/SGT
|
|
|
雲頂新耀宣佈治療原發性膜性腎病的新型BTK抑制劑EVER001在1b/2a期臨床試驗階段性數據中取得積極結果
Dec 4, 2024 10:59 HKT/SGT
|
|
|
云顶新耀宣布治疗原发性膜性肾病的新型BTK抑制剂EVER001在1b/2a期临床试验阶段性数据中取得积极结果
Dec 4, 2024 10:48 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|